Labros A. Karagounis

Increased incidence of Chlamydiaspecies within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease

Joseph B. Muhlestein, Elizabeth H. Hammond, John F. Carlquist et al. · Journal of the American College of Cardiology · 1996 · 421 citations

Coronary Arteries, Cardiovascular Disease, Public Health +5

An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: Results of a randomized study (ROMIO)

Miguel Ángel Gómez‐Bravo, Jeffrey L. Anderson, Labros A. Karagounis et al. · Journal of the American College of Cardiology · 1996 · 364 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Medicine +10

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.

J.L. Anderson, Labros A. Karagounis, Lewis C. Becker et al. · Circulation · 1993 · 287 citations · Full text

Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 Study Investigators.

Fidela Moreno, Thelma Villanueva, Labros A. Karagounis et al. · Circulation · 1994 · 248 citations · Full text

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study

Labros A. Karagounis, Sherman G. Sorensen, Ronald L. Menlove et al. · Journal of the American College of Cardiology · 1992 · 238 citations

Thrombosis, Cardiovascular Disease, Does Thrombolysis +12